Abstract: To provide a data relay device which prevents a significant delay even when pieces of data are transmitted/received in protocols that are different from each other. Transmission timings at which pieces of data are transmitted/received in a network using an event trigger type communication protocol are estimated. Stay periods which occur when pieces of data are relayed and transmitted at predetermined transmission timings in a network using a time trigger type communication protocol are calculated while changing a reference time for the time trigger type communication protocol. Then, synchronization processing is performed in the network using the time trigger type communication protocol such that communication is performed using a reference time having a small stay period that has been calculated.

Abstract: A data communication network system which enables an intended unit to determine a start point for a transmission schedule in communication is provided. In a data communication network system in which a plurality of electronic control units perform network communication through a communication line based on a time triggered communication protocol, a control section for previously putting the communication line in a communication inhibited state, and canceling the communication inhibited state at a predetermined time is included, and a predetermined one unit among the plurality of electronic control units transmits a message for synchronization, in a communication time, with the other units thereamong immediately after the communication inhibited state is cancelled.

Abstract: An object of the present invention is to provide an information processing terminal that specifies emotions from a voice and audio outputs music suitable for the specified emotions to enable the emotions of a loudspeaker who uttered the voice to be recognized readily. In an information processing terminal according to the present invention, an emotion inferring unit 23 detects, from sound information, at least two emotions of an utterer who uttered a voice included in the sound information, and a music data generating unit 24 synthesizes music data, stored in a music parts database 242 and corresponding to the emotions detected by the emotion inferring unit 23, and a controller 22 reproduces the music data generated by the music data generating unit 24.

Abstract: An object of the present invention is to provide an information processing terminal that specifies emotions from a voice and audio outputs music suitable for the specified emotions to enable the emotions of a loudspeaker who uttered the voice to be recognized readily. In an information processing terminal according to the present invention, an emotion inferring unit 23 detects, from sound information, at least two emotions of an utterer who uttered a voice included in the sound information, and a music data generating unit 24 synthesizes music data, stored in a music parts database 242 and corresponding to the emotions detected by the emotion inferring unit 23, and a controller 22 reproduces the music data generated by the music data generating unit 24.

Abstract: A protein having amino acid sequence in SEQ ID No.:1 of the Sequence Listing derived from human MP52, and a dimer protein thereof. A homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid sequence in SEQ ID No.:1 of the Sequence Listing with a methionine at the N-terminus, introducing the plasmid into E. coli for transformation, solubilizing inclusion bodies obtained by culturing the transformant, purifying the monomer protein from the solubilized solution, refolding the monomer protein into a dimer protein and purifying the same. The homodimer protein described above is useful as a pharmaceutical composition for treating cartilage and bone diseases.

Abstract: The structure of the patent is a substrate wherein a metal electrode, a dielectric thin film, and a further dielectric thin film are adhered onto a piezoelectric substrate. A substrate wherein elastic wave energy is confined in the piezoelectric substrate can be obtained. In particular, when a SiO2 thin film and an AlN thin film are used as thin films 4 and 5, respectively, a substrate excellent in an electromechanical coupling coefficient (k2) and a temperature characteristic of frequency can be yielded by making the film thicknesses of electrodes 2 and 3 and those of the thin films 4 and 5 into optimal values.

Abstract: A protein having amino acid sequence in SEQ ID No.:1 of the Sequence Listing derived from human MP52, and a dimer protein thereof. A homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid sequence in SEQ ID No.:1 of the Sequence Listing with a methionine at the N-terminus, introducing the plasmid into E. coli for transformation, solubilizing inclusion bodies obtained by culturing the transformant, purifying the monomer protein from the solubilized solution, refolding the monomer protein into a dimer protein and purifying the same. The homodimer protein described above is useful as a pharmaceutical composition for treating cartilage and bone diseases.

Abstract: An object of the present invention is to provide an information processing terminal that specifies emotions from a voice and audio outputs music suitable for the specified emotions to enable the emotions of a loudspeaker who uttered the voice to be recognized readily. In an information processing terminal according to the present invention, an emotion inferring unit 23 detects, from sound information, at least two emotions of an utterer who uttered a voice included in the sound information, and a music data generating unit 24 synthesizes music data, stored in a music parts database 242 and corresponding to the emotions detected by the emotion inferring unit 23, and a controller 22 reproduces the music data generated by the music data generating unit 24.

Abstract: A protein having amino acid sequence in SEQ ID NO: 1 of the Sequence Listing derived from human MP52, and a dimer protein thereof. A homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid sequence in SEQ ID NO: 1 of the Sequence Listing with a methionine at the N-terminus, introducing the plasmid into E. coli for transformation, solubilizing inclusion bodies obtained by culturing the transformant, purifying the monomer protein from the solubilized solution, refolding the monomer protein into a dimer protein and purifying the same. The homodimer protein described above is useful as a pharmaceutical composition for treating cartilage and bone diseases.

Abstract: A protein consisting of the amino acid sequence in SEQ ID No: 1 derived from human MP52 and a homodimer protein thereof useful for treating cartilage and/or bone diseases and a process for its preparation.

Abstract: A protein having amino acid sequence in SEQ ID No.: 1 of the Sequence Listing derived from human MP52, and a dimer protein thereof. A homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid sequence in SEQ ID No.: 1 of the Sequence Listing with a methionine at the N-terminus, introducing the plasmid into E. coli for transformation, solubilizing inclusion bodies obtained by culturing the transformant, purifying the monomer protein from the solubilized solution, refolding the monomer protein into a dimer protein and purifying the same.

Abstract: A compound of the formula wherein the substituents are as defined in the specification and solvates and salts thereof useful for treating bone and cartilage diseases.

Abstract: Compounds useful as preventive and therapeutic agents for bone and cartilage diseases; and drug compositions containing the same. The compounds are polyhydroxyphenol derivatives of general formula (I) and quinione analogues derived therefrom (wherein R1 is alkyl, optionally substituted benzyl or optionally substituted aryl; R2 is hydrogen, alkyl, alkenyl or optionally substituted benzyl; R3 is hydrogen, alkyl, alkenyl, optionally substituted benzyl, hydroxyl, alkoxy, alkenyloxy or optionally substituted benzyloxy; R4 is hydrogen, alkyl, alkenyl, optionally substituted benzyl or hydroxyl; and R5 and R6 are each independently hydrogen, alkyl, alkenyl or optionally substituted benzyl). The polyhydroxyphenol derivatives and the quinone analogues exhibit a potent inhibitory activity against bone resorption and are useful as preventive and therapeutic agents for bone and cartilage diseases.

Abstract: A pharmaceutical composition containing as an active ingredient glimepiride. The composition is used for preventing or treating arteriosclerosis with no influence on lipid metabolism and no increase in plasma insulin level.